ShigETEC

N/A

Report date: 2026/04/10 20:01:49

Base Information

Drug NameShigETEC
Drug Alias NameShigETEC live, attenuated, oral vaccineShigella-ETEC vaccine (Eveliqure Biotechnologies)
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsDiarrheaGastrointestinal DiseasesDysentery, Bacillary +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesHungaryBangladesh
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEveliqure Biotechnologies GmbH
China Registration ClassN/A

Develop Information

Active CompaniesEveliqure Biotechnologies GmbHSerum Institute Of India Ltd
Inactive CompaniesN/A
Active IndicationsDiarrheaGastrointestinal DiseasesDysentery, Bacillary +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A